ORKA Return on Tangible Equity | Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. (ORKA) Return on Tangible Equity

2026-06-30: Return Tang Equity -11.92%.
2026-03-31: Return Tang Equity -23.89%.
2025-12-31: Return Tang Equity -22.34%.
2025-09-30: Return Tang Equity -21.46%.

Complete source-backed return tang equity history.

Available history: 2004-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-11.92%
2026-03-31	-23.89%
2025-12-31	-22.34%
2025-09-30	-21.46%
2025-06-30	-28.06%
2025-03-31	-20.25%
2024-09-30	-15.76%
2024-06-30	92.35%
2024-03-31	85.03%
2023-12-31	-14.42%
2023-09-30	-14.29%
2023-06-30	-16.14%
2023-03-31	-19.74%
2022-12-31	-23.82%
2022-09-30	-33.77%
2022-06-30	-37.38%
2022-03-31	-38.58%
2021-12-31	-37.85%
2021-09-30	-33.16%
2021-06-30	-26.22%
2021-03-31	-18.99%
2020-12-31	-20.93%
2020-09-30	-11.57%
2020-06-30	-48.56%
2020-03-31	-81.48%
2019-12-31	-72.04%
2019-09-30	-65.29%
2019-06-30	-67.28%
2019-03-31	-93.77%
2018-12-31	-131.52%
2018-09-30	-142.58%
2018-06-30	-149.82%
2018-03-31	-152.77%
2017-12-31	-179.95%
2017-09-30	-129.16%
2017-06-30	-127.23%
2017-03-31	-95.00%
2016-12-31	-74.09%
2016-09-30	-58.04%
2016-06-30	-43.78%
2016-03-31	-35.70%
2015-12-31	-30.06%
2015-09-30	-26.50%
2015-06-30	-23.67%
2015-03-31	-82.82%
2014-12-31	-65.73%
2014-09-30	-58.29%
2014-06-30	-48.98%
2014-03-31	-38.34%
2013-12-31	-44.54%
2013-09-30	-26.31%
2013-06-30	-20.15%
2013-03-31	-120.33%
2012-12-31	-148.61%
2012-09-30	-160.89%
2012-06-30	-182.69%
2012-03-31	-104.80%
2011-12-31	-93.58%
2011-09-30	-92.97%
2011-06-30	-74.39%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-22.34%
2023-12-31	-14.42%
2022-12-31	-23.82%
2021-12-31	-37.85%
2020-12-31	-20.93%
2019-12-31	-72.04%
2018-12-31	-131.52%
2017-12-31	-179.95%
2016-12-31	-74.09%
2015-12-31	-30.06%
2014-12-31	-65.73%
2013-12-31	-44.54%
2012-12-31	-148.61%
2011-12-31	-93.58%
2010-12-31	-124.35%
2009-12-31	-123.29%
2008-12-31	50.90%
2007-12-31	71.08%
2006-12-31	91.24%
2005-12-31	215.19%
2004-12-31	82.55%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Liquidia Corp (LQDA)	United States	$6.347B	51.23
Veradermics, Inc (MANE)	United States	$4.839B